FDA Intelligence | FDA

Advertising and Promotion

Nov 3, 2025
Industry Waits To See If FDA Makes Good on DTC Regulation Promise
Oct 6, 2025
FDA’s SIUU Guidance: What Now?
Sep 12, 2025
Questions Abound as FDA DTC Advertising Crackdown Begins
Aug 26, 2025
MAHA Report May Force Companies To Reexamine DTC Promotions
Jul 21, 2025
Continuing To Innovate During Regulatory Uncertainty
Jul 3, 2025
DTC Ads in Political Crosshairs with No ‘Easy Fix’ in Sight
Jun 2, 2025
The Promotional Review Committee Continues To Be the Gatekeeper in Omnichannel Marketing
Jun 1, 2025
AI Is Coming to the FDA’s Review of Promotional Materials
Apr 22, 2025
What To Do When the Regulators Go Away?
Mar 27, 2025
OPDP Oversight and Enforcement Is Alive and Well in New Administration

Good Clinical Practice

Nov 15, 2018
Don’t Overlook Institutional Conflicts of Interest
Oct 30, 2018
Targeting Trial Recruitment Ads Can Be Tricky
May 2, 2018
Investigator Brochures in Early Trials Found Wanting
May 2, 2018
Audit Finds Non-Profits Fall Short on Trial Transparency Policies
Dec 8, 2017
More Transparency Needed in Nutrition Research
Nov 27, 2017
Practice of Excluding Prior Cancer Survivors from Clinical Trials Needs To Be Re-examined
Sep 15, 2017
NIH Releases Tools To Aid Researchers in Implementing Recent Trial Policy Changes
Aug 23, 2017
Number of FDA BIMO Inspections Drop Nearly 10 Percent in FY 2016
Aug 18, 2017
IRBs Need To Rethink Payments to Research Subjects

Food Labeling

Aug 11, 2020
It’s More than a New Graphic: How the New Nutrition Facts Panel Can Impact a Food’s Labeling, Marketing and Formulation
Sep 18, 2017
CFSAN Wants Ideas on Reducing Regulatory Burdens
Sep 18, 2017
FDA Allows First Qualified Health Claim To Prevent Food Allergy
Aug 15, 2017
Rulemakings on Bioengineered Food, Revision of Facts Panel Are ’Inactive’

FDA Regulation & Enforcement

Medical Devices

Copyright © Thompson FDA, a division of CBIS. All rights reserved.